Effect of Prophylactic Use of Intranasal Oil Formulations in the Hamster Model of COVID-19
Open Access
- 14 October 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 12, 746729
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection initiates with viral entry in the upper respiratory tract, leading to coronavirus disease 2019 (COVID-19). Severe COVID-19 is characterized by pulmonary pathologies associated with respiratory failure. Thus, therapeutics aimed at inhibiting the entry of the virus or its internalization in the upper respiratory tract are of interest. Herein, we report the prophylactic application of two intranasal formulations provided by the National Medicinal Plant Board (NMPB), Anu oil and til tailya, in the hamster model of SARS-CoV-2 infection. Prophylactic intra-nasal instillation of these oil formulations exhibited reduced viral load in lungs and resulted in reduced body weight loss and lung-pneumonitis. In line with reduced viral load, histopathological analysis revealed a reduction in lung pathology in the Anu oil group as compared to the control infected group. However, the til tailya group did not show a significant reduction in lung pathology. Furthermore, molecular analysis using mRNA expression profiling indicated reduced expression of pro-inflammatory cytokine genes, including Th1 and Th17 cytokines for both the intranasal formulations as a result of decreased viral load. Together, the prophylactic intranasal application of Anu oil seems to be useful in limiting both viral load and severity in SARS-CoV2 infection in the hamster model.Keywords
All Related Versions
Funding Information
- Department of Biotechnology, Ministry of Science and Technology, India
- National Medicinal Plants Board, Ministry of AYUSH, Government of India
This publication has 53 references indexed in Scilit:
- Reinventing nano drug delivery systems for hydrophilic active ingredients in Ayurvedic lipid based formulations containing poly herbal decoctionJournal of Ayurveda and Integrative Medicine, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2)Journal of Integrative Medicine, 2020
- Evidence of CD1d pathway of lipid antigen presentation in mouse primary lung epithelial cells and its up-regulation upon Mycobacterium bovis BCG infectionPLOS ONE, 2018
- Transcription factor Foxo1 is essential for IL-9 induction in T helper cellsNature Communications, 2017
- Hypoxia-induced angiotensin II by the lactate-chymase-dependent mechanism mediates radioresistance of hypoxic tumor cellsScientific Reports, 2017
- Role of Kasahara Dashemani Vati in Kasa and Vyadhikshamatva in children with special reference to recurrent respiratory tract infectionsAYU (An International Quarterly Journal of Research in Ayurveda), 2013
- Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injuryAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2003
- Regulatory Effects of Eotaxin on Acute Lung Inflammatory InjuryThe Journal of Immunology, 2001
- Surfactant protein-D and pulmonary host defenseRespiratory Research, 2000